Home > Cashflow Statement > WINDLAS BIOTECH

WINDLAS BIOTECH
Cash Flow from Operating Activities

    Back to Cashflow Statement
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹68 Cr₹109 Cr₹61 Cr₹9.13 Cr₹11 Cr

What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?

The latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH is ₹68 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹68 Cr
Mar2024₹109 Cr
Mar2023₹61 Cr
Mar2022₹9.13 Cr
Mar2021₹11 Cr

How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹68 Cr
-37.42
Mar2024 ₹109 Cr
78.73
Mar2023 ₹61 Cr
567.74
Mar2022 ₹9.13 Cr
-20.30
Mar2021 ₹11 Cr -

Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,533.4 Cr -0.5% -8.2% -20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

-0.5%

-8.2%

-20.1%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses